RUBY - ルビウス・セラピュ―ティクス （Rubius Therapeutics Inc.） ルビウス・セラピュ―ティクスRUBYのチャート
RUBYの企業情報
| symbol | RUBY |
|---|---|
| 会社名 | Rubius Therapeutics Inc （ルビウス・セラピュ―ティクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Biological Products (No Diagnostic Substances) |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 Rubius Therapeutics Inc is a biotechnology company that develops cellular therapies for cancer and enzyme deficiency diseases. The Company develops Red-Cell Therapeutics (RCT) products using red platform. RCT is a red blood cell-based therapy for applications in cancer enzyme replacement therapies and autoimmune disease and tolerance induction. Its RCT product candidate is designed to provide various attributes which include broad therapeutic applications predictable bio-distribution and advantageous tolerability. It is initially focused on advancing RCT product candidates for patients suffering from rare diseases cancer and autoimmune diseases based on three modalities - cellular shielding potent cell-cell interaction and tolerance induction. Its product candidates in rare diseases include RTX-134 for the treatment of phenylketonuria (PKU) RTX-134 followed by RTX-Uricase and RTX-CBS for the treatment of chronic refractory gout symptomatic homocystinuria. ルビウス・セラピュ―ティクスは米国のバイオ医薬品企業。主に重症患者のための赤血球治療薬の開発に従事する。同社の候補薬はフェニルケトン尿症、ホモシスチン尿症、慢性不応性痛風、急性ポルフィリン症、固形腫瘍、血液がん、自己免疫疾患などの治療に使用される。本社所在地はマサチュ―セッツ州ケンブリッジ。 Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics™. The Company's proprietary RED PLATFORM® was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and off-the-shelf allogeneic cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. |
| 本社所在地 | 325 Vassar Street Suite 1A Cambridge MA 02139 USA |
| 代表者氏名 | David R. Epstein David R. Epstein |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 617-679-9600 |
| 設立年月日 | 41365 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2018年 |
| 従業員数 | 83人 |
| url | www.rubiustx.com |
| nasdaq_url | https://www.nasdaq.com/symbol/ruby |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -72.29900 |
| 終値（lastsale） | 17.01 |
| 時価総額（marketcap） | 1344514677.03 |
| 時価総額 | 時価総額（百万ドル） 1354 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 1432.92 |
| 当期純利益 | 当期純利益（百万ドル） -73.79000 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Rubius Therapeutics Inc revenues was not reported. Net loss applicable to common stockholders increased from $15.1M to $44.4M. Higher net loss reflects Research and Development - Balancing increase from $7.3M to $19.9M (expense) Stock-based Compensation in SGA increase from $3.5M to $15.5M (expense) General and Administrative - Balancing increase from $1.9M to $6.6M (expense). |
RUBYのテクニカル分析
RUBYのニュース
Current Stocks on the Move: Rubius Therapeutics, Inc. (NASDAQ:RUBY -15.66%), Canopy Growth Corporation (NASDAQ:CGC -1.76%) 2023/03/07 17:01:07 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Current Stocks on the Move: Rubius Therapeutics, Inc. (NASDAQ:RUBY -15.66%), Canopy Growth Corporation (NASDAQ:CGC -1.76%) appeared first on Stocks Equity .
This stocks will boost Up Your investment: Rubius Therapeutics, Inc. (NASDAQ:RUBY -33.55%), Farfetch Limited (NYSE:FTCH -2.59%) 2023/03/07 13:07:36 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post This stocks will boost Up Your investment: Rubius Therapeutics, Inc. (NASDAQ:RUBY -33.55%), Farfetch Limited (NYSE:FTCH -2.59%) appeared first on Stocks Equity .
US stock market closed mixed, Dow Jones up 0.12% 2023/03/07 02:17:34 InstaForex
At the close of the New York Stock Exchange, the Dow Jones rose 0.12%, the S&P 500 rose 0.07%, and the NASDAQ Composite fell 0.11%. Markets are also awaiting information from the US labor market, which will be published on Friday. According to market strategist at Nikko Asset Management John Weil, the data for February may turn out to be worse than in January, and this will calm investors a bit in their fears of too sharp tightening of monetary policy. Merck & Company Inc was the top performer among the components of the Dow Jones index today, up 4.22 points or 3.95% to close at 111.10. Apple Inc rose 2.80 points or 1.85% to close at 153.83. Coca-Cola Co rose 0.92 points or 1.55% to close at 60.36. Shares of Dow Inc became the leaders of the fall, the price of which fell by 1.21 points (2.07%), ending the session at 57.11. Walgreens Boots Alliance Inc was up 1.77% or 0.64 points to close at 35.45, while Intel Corporation was down 1.55% or 0.41 points to close at 25. .99 Leading gainers among the components of the S&P 500 in today''s trading were Lumen Technologies Inc, which rose 4.10% to 3.30, Merck & Company Inc, which gained 3.95% to close at 111.10. as well as Enphase Energy Inc, which rose 3.77% to end the session at 225.35.
Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 2023/03/03 13:24:29 Benzinga
Gainers ObsEva SA (NASDAQ: OBSV ) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Bullfrog AI Holdings, Inc. (NASDAQ: BFRG ) rose 53.1% to $4.18 in pre-market trading. Bullfrog AI recently priced its IPO at $6.50 per share. Rubius Therapeutics, Inc. (NASDAQ: RUBY ) rose 28.7% to $0.1461 in pre-market trading. Rubius Therapeutics recently outlined dissolution plan, after unsuccessful attempt on alternatives. Smart for Life, Inc. (NASDAQ: SMFL ) rose 19.7% to $0.2278 in pre-market trading. Smart for Life is scheduled to hold shareholder meeting on March 15, 2023. HUB Cyber Security (Israel) Ltd. (NASDAQ: HUBC ) rose 17.6% to $1.47 in pre-market trading after dipping 21% on Thursday. Heritage Insurance Holdings, Inc. (NASDAQ: HRTG ) rose 15.4% to $3.14 in pre-market trading after posting Q4 results. C3.ai, Inc. (NYSE: AI ) shares rose 15% to $24.51 in pre-market trading after the company reported better-than-expected Q3 results and issued strong guidance.
Results from Rubius Therapeutics Inc. (RUBY) show risk 2023/02/27 16:24:00 US Post News
As of Friday, Rubius Therapeutics Inc.’s (NASDAQ:RUBY) stock closed at $0.12, down from $0.14 the previous day. While Rubius Therapeutics Inc. has underperformed by -14.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RUBY fell by -97.37%, with highs and lows ranging from $6.18 to $0.12, […]
US stock market closed mixed, Dow Jones up 0.12% 2023/03/07 02:17:34 InstaForex
At the close of the New York Stock Exchange, the Dow Jones rose 0.12%, the S&P 500 rose 0.07%, and the NASDAQ Composite fell 0.11%. Markets are also awaiting information from the US labor market, which will be published on Friday. According to market strategist at Nikko Asset Management John Weil, the data for February may turn out to be worse than in January, and this will calm investors a bit in their fears of too sharp tightening of monetary policy. Merck & Company Inc was the top performer among the components of the Dow Jones index today, up 4.22 points or 3.95% to close at 111.10. Apple Inc rose 2.80 points or 1.85% to close at 153.83. Coca-Cola Co rose 0.92 points or 1.55% to close at 60.36. Shares of Dow Inc became the leaders of the fall, the price of which fell by 1.21 points (2.07%), ending the session at 57.11. Walgreens Boots Alliance Inc was up 1.77% or 0.64 points to close at 35.45, while Intel Corporation was down 1.55% or 0.41 points to close at 25. .99 Leading gainers among the components of the S&P 500 in today''s trading were Lumen Technologies Inc, which rose 4.10% to 3.30, Merck & Company Inc, which gained 3.95% to close at 111.10. as well as Enphase Energy Inc, which rose 3.77% to end the session at 225.35.
Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 2023/03/03 13:24:29 Benzinga
Gainers ObsEva SA (NASDAQ: OBSV ) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Bullfrog AI Holdings, Inc. (NASDAQ: BFRG ) rose 53.1% to $4.18 in pre-market trading. Bullfrog AI recently priced its IPO at $6.50 per share. Rubius Therapeutics, Inc. (NASDAQ: RUBY ) rose 28.7% to $0.1461 in pre-market trading. Rubius Therapeutics recently outlined dissolution plan, after unsuccessful attempt on alternatives. Smart for Life, Inc. (NASDAQ: SMFL ) rose 19.7% to $0.2278 in pre-market trading. Smart for Life is scheduled to hold shareholder meeting on March 15, 2023. HUB Cyber Security (Israel) Ltd. (NASDAQ: HUBC ) rose 17.6% to $1.47 in pre-market trading after dipping 21% on Thursday. Heritage Insurance Holdings, Inc. (NASDAQ: HRTG ) rose 15.4% to $3.14 in pre-market trading after posting Q4 results. C3.ai, Inc. (NYSE: AI ) shares rose 15% to $24.51 in pre-market trading after the company reported better-than-expected Q3 results and issued strong guidance.
Results from Rubius Therapeutics Inc. (RUBY) show risk 2023/02/27 16:24:00 US Post News
As of Friday, Rubius Therapeutics Inc.’s (NASDAQ:RUBY) stock closed at $0.12, down from $0.14 the previous day. While Rubius Therapeutics Inc. has underperformed by -14.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RUBY fell by -97.37%, with highs and lows ranging from $6.18 to $0.12, […]
Current Stocks’s Buzzers: Rubius Therapeutics, Inc. (NASDAQ:RUBY), Blue Apron Holdings, Inc. (NYSE:APRN) 2023/02/24 17:35:08 Stock Equity
RUBY has seen its SMA50 which is now -38.36%. In looking the SMA 200 we see that the stock has seen a -76.97%. APRN has seen its SMA50 which is … The post Current Stocks’s Buzzers: Rubius Therapeutics, Inc. (NASDAQ:RUBY), Blue Apron Holdings, Inc. (NYSE:APRN) appeared first on Stocks Equity .
Rubius Therapeutics Outlines Dissolution Plan, After Unsuccessful Attempt On Alternatives 2023/02/22 17:00:14 Benzinga
Full story available on Benzinga.com
Why Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 2023/03/03 13:24:29 Benzinga
Gainers ObsEva SA (NASDAQ: OBSV ) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Bullfrog AI Holdings, Inc. (NASDAQ: BFRG ) rose 53.1% to $4.18 in pre-market trading. Bullfrog AI recently priced its IPO at $6.50 per share. Rubius Therapeutics, Inc. (NASDAQ: RUBY ) rose 28.7% to $0.1461 in pre-market trading. Rubius Therapeutics recently outlined dissolution plan, after unsuccessful attempt on alternatives. Smart for Life, Inc. (NASDAQ: SMFL ) rose 19.7% to $0.2278 in pre-market trading. Smart for Life is scheduled to hold shareholder meeting on March 15, 2023. HUB Cyber Security (Israel) Ltd. (NASDAQ: HUBC ) rose 17.6% to $1.47 in pre-market trading after dipping 21% on Thursday. Heritage Insurance Holdings, Inc. (NASDAQ: HRTG ) rose 15.4% to $3.14 in pre-market trading after posting Q4 results. C3.ai, Inc. (NYSE: AI ) shares rose 15% to $24.51 in pre-market trading after the company reported better-than-expected Q3 results and issued strong guidance.
Results from Rubius Therapeutics Inc. (RUBY) show risk 2023/02/27 16:24:00 US Post News
As of Friday, Rubius Therapeutics Inc.’s (NASDAQ:RUBY) stock closed at $0.12, down from $0.14 the previous day. While Rubius Therapeutics Inc. has underperformed by -14.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RUBY fell by -97.37%, with highs and lows ranging from $6.18 to $0.12, […]
Current Stocks’s Buzzers: Rubius Therapeutics, Inc. (NASDAQ:RUBY), Blue Apron Holdings, Inc. (NYSE:APRN) 2023/02/24 17:35:08 Stock Equity
RUBY has seen its SMA50 which is now -38.36%. In looking the SMA 200 we see that the stock has seen a -76.97%. APRN has seen its SMA50 which is … The post Current Stocks’s Buzzers: Rubius Therapeutics, Inc. (NASDAQ:RUBY), Blue Apron Holdings, Inc. (NYSE:APRN) appeared first on Stocks Equity .